Form 8-K - Current report:
SEC Accession No. 0000950136-08-003324
Filing Date
2008-07-01
Accepted
2008-07-01 11:27:59
Documents
2
Period of Report
2008-07-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K file1.htm 8-K 13282
2 PRESS RELEASE file2.htm EX-99.1 7653
  Complete submission text file 0000950136-08-003324.txt   22675
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 08928355
SIC: 2836 Biological Products, (No Diagnostic Substances)